NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • XYZ.
  • XY.
  • #TrumpTrade
  • Invest ↗
Sign in Subscribe

USA Rare Earth Wins Outperform Rating Amid Government Funding Prospects

William Blair gives USA Rare Earth an Outperform rating, citing its integrated operations, proprietary technology, and potential for significant U.S. government investment.

USA Rare Earth Wins Outperform Rating Amid Government Funding Prospects
Credit: MP Materials via AP
Already have an account? Sign in.
Featured/ 10/20/2025 · 6:42 AM
USAR
/ Read more

Feed↓

Replimune Group
10/20/2025 · 9:46 AM

Replimune Gets FDA Nod for RP1 Drug Resubmission

Replimune's RP1 melanoma treatment gets FDA acceptance for BLA resubmission with April 2026 review date. Wedbush upgrades stock to Outperform with $18 target as approval odds improve.

/ Subscriber only
Cogent Biosciences logo
10/20/2025 · 9:23 AM

Cogent Biosciences Receives FDA Breakthrough Designation for Mastocytosis Treatment

Cogent Biosciences announces FDA Breakthrough Therapy Designation for bezuclastinib, a promising treatment for NonAdvanced Systemic Mastocytosis with NDA submission planned by year-end 2025.

/ Subscriber only
Cleveland-Cliffs
Featured/ 10/20/2025 · 9:06 AM

Cleveland-Cliffs Explores Rare Earths After Beating Q3 Targets

Steel maker Cleveland-Cliffs beats Q3 earnings expectations and reveals rare-earth exploration plans at Michigan and Minnesota mines to reduce China dependence.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe